V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000112 | 230000067 | 1.57 | 51.4 | Palliative (P) | 2016-04-03 | 2016-04-20 | Cisplatin + Radiotherapy | N | N | 230021479 | CARBO + FLUOROURACIL |
| 230000113 | 230000067 | 1.75 | 84.5 | Adjuvant (A) | null | 2014-01-06 | Docetaxel | N | N | 230021479 | CAPECITABINE + OXALIPLATIN |
| 230000114 | 230000068 | 1.8 | 95 | Adjuvant (A) | 2017-01-02 | 2017-01-02 | Capecitabine + Oxaliplatin 21day | 02 | N | 230021651 | CAPECITABINE |
| 230000115 | 230000068 | null | null | Palliative (P) | null | 2016-01-22 | Bevacizumab + Cape + Oxali 14day | N | N | 230021651 | CAPECITABINE + OXALIPLATIN |
| 230000116 | 230000068 | 1.7 | 117 | Curative (C) | null | 2013-12-10 | CAPECITABINE + OXALIPLATIN | Y | N | 230021651 | GEMCITABINE |
| 230000117 | 230000069 | 1.76 | 73 | Palliative (P) | 2014-12-16 | 2014-12-17 | Capecitabine + Oxaliplatin 21day | 02 | N | 230021677 | OXALIPLATIN + MDG |
| 230000118 | 230000070 | 1.58 | 79 | Adjuvant (A) | 2017-12-20 | 2018-01-11 | Carboplatin AUC 2 - 5 | N | Y | 230021886 | OXALIPLATIN + MDG |
| 230000119 | 230000071 | null | 50.8 | Adjuvant (A) | 2017-10-09 | 2017-10-09 | CAPECITABINE + RT | 02 | N | 230021916 | CAPECITABINE + RT |
| 230000120 | 230000072 | 1.69 | 78 | Disease modification (D) | 2014-06-07 | 2014-06-07 | CAPECITABINE + RT | N | N | 230022008 | CAPECITABINE + RT |
| 230000121 | 230000072 | 1.72 | 84.1 | Curative (C) | 2016-11-02 | 2016-11-14 | CAPECITABINE + OXALIPLATIN | 02 | N | 230022008 | OXALIPLATIN + MDG |
| 230000122 | 230000073 | 1.66 | null | Disease modification (D) | 2018-03-01 | 2018-03-10 | Cisplatin+Gemcitabine (gallbladder) | 2 | N | 230022131 | OXALIPLATIN + MDG |
| 230000123 | 230000074 | 1.76 | 73 | null | 2014-10-07 | 2014-10-13 | VANDETANIB | 02 | null | 230022136 | CAPECITABINE + OXALIPLATIN |
| 230000124 | 230000074 | 1.88 | 103 | Adjuvant (A) | 2014-03-23 | 2014-03-23 | CVP R | 02 | N | 230022136 | CAPECITABINE + OXALIPLATIN |
| 230000125 | 230000074 | 1.64 | 88 | Palliative (P) | 2016-08-25 | 2016-08-25 | Cisplatin + Doxorubicin | 02 | N | 230022136 | CAPECITABINE + OXALIPLATIN |
| 230000126 | 230000074 | 1.65 | 70.9 | Adjuvant (A) | 2016-03-30 | 2016-04-13 | Capecitabine | 02 | N | 230022136 | CAPECITABINE |
| 230000127 | 230000075 | 1.63 | 99 | Curative (C) | 2018-01-11 | 2018-01-14 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 230022206 | CAPECITABINE + RT |
| 230000128 | 230000076 | 1.56 | null | Palliative (P) | 2016-09-29 | 2016-10-10 | CHOP R - 21 days | 02 | N | 230022266 | CAPECITABINE + OXALIPLATIN |
| 230000129 | 230001085 | 1.71 | 95.4 | Curative (C) | 2016-02-04 | 2016-02-22 | VANDETANIB | N | Y | 230022320 | CAPECITABINE + OXALIPLATIN |
| 230000130 | 230001085 | 1.68 | null | Curative (C) | null | 2016-06-14 | CISPLATIN + RT | N | Y | 230022320 | ARISTOTLE TRIAL |
| 230000135 | 230000078 | 1.49 | 99.8 | Palliative (P) | 2016-06-15 | 2016-06-26 | Carboplatin AUC 2 - 5 | 02 | N | 230022517 | OXALIPLATIN + MDG |
| 230000136 | 230000079 | 2 | 88.5 | null | 2015-04-02 | 2015-04-02 | CHOP R - 21 days | 02 | null | 230022553 | CAPECITABINE + RT |
| 230000137 | 230001087 | 1.66 | null | Curative (C) | 2017-08-14 | 2017-08-22 | Capecitabine | N | N | 230022704 | BEVACIZUMAB + CAPECITABINE |
| 230000138 | 230000080 | 1.71 | 72.2 | Curative (C) | 2014-09-01 | 2014-09-01 | GEFITINIB | 2 | Y | 230022786 | CAPECITABINE + OXALIPLATIN |
| 230000139 | 230000081 | 1.7 | 77.9 | Not known (9) | 2014-06-09 | 2014-06-10 | Sorafenib | N | N | 230022833 | CAPECITABINE + OXALIPLATIN |
| 230000140 | 230000082 | 1.54 | 97.8 | Palliative (P) | 2018-01-03 | 2018-01-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | 230022873 | CAPECITABINE |
| 230000141 | 230000082 | 1.63 | 74.8 | Palliative (P) | 2015-12-09 | 2015-12-31 | CHOP R - 21 days | N | null | 230022873 | FLUOROURACIL |
| 230000142 | 230000083 | 1.72 | null | null | 2017-02-08 | 2017-02-09 | CAPECITABINE + OXALIPLATIN | N | null | 230022986 | CAPECITABINE + OXALIPLATIN |
| 230000143 | 230000084 | null | null | Curative (C) | 2017-08-01 | 2018-05-19 | VANDETANIB | N | Y | 230023012 | SCOT TRIAL |
| 230000144 | 230000085 | 1.68 | null | Palliative (P) | 2013-09-05 | 2013-09-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | 230023028 | CAPECITABINE + OXALIPLATIN |
| 230000145 | 230000086 | 1.73 | null | Palliative (P) | 2016-04-26 | 2016-05-20 | Irinotecan + Modified De Gramont | N | N | 230023172 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230000146 | 230000086 | 1.62 | 56.5 | Adjuvant (A) | 2016-12-28 | 2016-12-28 | Cisplatin + Doxorubicin | N | N | 230023172 | CAPECITABINE |
| 230000147 | 230000086 | 1.57 | 75.3 | Neo-adjuvant (N) | 2015-01-05 | 2015-01-09 | Capecitabine + Oxaliplatin 21day | 2 | N | 230023172 | CAPECITABINE + OXALIPLATIN |
| 230000148 | 230000087 | 1.73 | 58.5 | Neo-adjuvant (N) | 2015-05-02 | 2015-05-15 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 230023365 | IRINOTECAN + MDG |
| 230000149 | 230000088 | 1.71 | 68 | Adjuvant (A) | 2015-08-24 | 2015-09-15 | VANDETANIB | N | N | 230023453 | CAPECITABINE |
| 230000150 | 230000089 | 1.7 | 61.3 | Palliative (P) | 2017-10-20 | 2017-10-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 230023492 | CAPECITABINE |
| 230000151 | 230000089 | 1.78 | 69.9 | Palliative (P) | 2013-09-20 | 2013-09-20 | Sorafenib | 2 | N | 230023492 | PANITUMUMAB |
| 230000152 | 230000089 | 1.7 | 79.8 | Neo-adjuvant (N) | 2015-11-09 | 2015-11-21 | CAPECITABINE + OXALIPLATIN | 2 | null | 230023492 | CARBOPLATIN + VINORELBINE |
| 230000153 | 230000089 | 1.66 | 47.2 | Adjuvant (A) | null | 2017-02-02 | CTD | N | N | 230023492 | FLUOROURACIL |
| 230000154 | 230000090 | 1.71 | 60.3 | Curative (C) | 2013-06-28 | 2013-06-28 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | Y | 230023630 | CAPECITABINE + OXALIPLATIN |
| 230000155 | 230000091 | 1.76 | 107 | Curative (C) | 2014-08-17 | 2014-09-04 | CISPLATIN + FLUOROURACIL | 02 | Y | 230023652 | CAPECITABINE + OXALIPLATIN |
| 230000156 | 230000092 | 1.6 | 69 | Not known (9) | 2016-09-19 | 2016-10-10 | Cisplatin + Radiotherapy | N | null | 230023728 | CAPECITABINE + OXALIPLATIN |
| 230000157 | 230000093 | null | 54 | Palliative (P) | 2015-05-09 | 2015-05-16 | Carboplatin + Etoposide iv&po | N | null | 230023737 | TRIAL |
| 230000158 | 230000094 | 1.71 | 74.7 | Palliative (P) | 2018-07-03 | 2018-07-03 | Capecitabine + Oxaliplatin 21day | N | N | 230023790 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 230000159 | 230000095 | 1.51 | 68.3 | Disease modification (D) | 2017-05-11 | 2017-05-23 | Oxaliplatin + Modified de Gramont | N | N | 230023836 | CAPECITABINE |
| 230000160 | 230000095 | 1.68 | 87.6 | Adjuvant (A) | 2015-11-10 | 2015-11-18 | Cetuximab + FOLFIRI cycle1 | 02 | N | 230023836 | CARBOPLATIN + ETOPOSIDE |
| 230000161 | 230000096 | 1.66 | 113.1 | Palliative (P) | 2018-01-15 | 2018-01-22 | Capecitabine 35days + RT | N | N | 230023867 | CAPECITABINE + RT |
| 230000162 | 230000096 | 1.63 | 79.05 | Curative (C) | 2017-09-18 | 2017-09-24 | CAP + RT | null | null | 230023867 | OXALIPLATIN + MDG |
| 230000163 | 230000096 | null | 73 | Adjuvant (A) | 2014-04-11 | 2014-04-23 | Oxaliplatin + Modified de Gramont | 02 | N | 230023867 | OXALIPLATIN + MDG |
| 230000164 | 230000097 | 1.83 | 70.3 | Palliative (P) | 2016-07-02 | 2016-07-02 | CHOP R | 2 | N | 230024113 | FLUOROURACIL |
| 230000165 | 230000098 | 1.5 | 61.3 | Palliative (P) | 2017-08-15 | 2017-09-04 | Capecitabine | N | N | 230024143 | CAPECITABINE + OXALIPLATIN |